Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2022/4/18 申報
- 申報編號
- 0001209191-22-024679
- 申報時間
- 2022/4/18
- 交易日
- 2022/4/14
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $28.0 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/4/14 | Class A Common Stock | M行使選擇權取得 | +44,010 | $2.48 | +$109,144.8 | 384,134 | 直接 | |
| 2022/4/14 | Class A Common Stock | S賣出處分 | −16,017 | $7.62F2 | −$122,049.54 | 368,117 | 直接 | |
| 2022/4/14 | Class A Common Stock | C轉換取得 | +18,500 | $0.00F4 | $0 | 386,617 | 直接 | |
| 2022/4/14 | Class A Common Stock | S賣出處分 | −18,500 | $7.51F5 | −$138,935 | 368,117 | 直接 | |
| 2022/4/14 | Class A Common Stock | C轉換取得 | +500 | $0.00F4 | $0 | 500 | 間接 | |
| 2022/4/14 | Class A Common Stock | S賣出處分 | −500 | $7.50F6 | −$3,750 | 0 | 間接 | |
| 2022/4/14 | Class A Common Stock | C轉換取得 | +1,000 | $0.00F4 | $0 | 1,000 | 間接 | |
| 2022/4/14 | Class A Common Stock | S賣出處分 | −1,000 | $7.51F6 | −$7,510 | 0 | 間接 | |
| 2022/4/14 | Class A Common Stock | C轉換取得 | +1,000 | $0.00F4 | $0 | 1,000 | 間接 | |
| 2022/4/14 | Class A Common Stock | S賣出處分 | −1,000 | $7.51F6 | −$7,510 | 0 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/4/14 | Class A Common Stock | C轉換處分 | −6,948,334 | $0.00F4 | $0 | 6,948,334 | 直接 | |
| 2022/4/14 | Class A Common Stock | M行使選擇權處分 | −1,251,304 | $0.00 | $0 | 1,251,304 | 直接 | |
| 2022/4/14 | Class A Common Stock | C轉換處分 | −547,500 | $0.00F4 | $0 | 547,500 | 間接 | |
| 2022/4/14 | Class A Common Stock | C轉換處分 | −545,000 | $0.00F4 | $0 | 545,000 | 間接 | |
| 2022/4/14 | Class A Common Stock | C轉換處分 | −141,875 | $0.00F4 | $0 | 141,875 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $7.61 to $7.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
表 I 有 4 筆、表 II 有 4 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $7.35 to $7.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $7.36 to $7.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 3 筆交易的價格引用這則附註。